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GFPWe have made improvements to E1-deleted adenovirus (Ad) transducing vectors that both substantially
reduce the innate inﬂammatory response provoked by the virus in BALB/c mouse ears and increase the
duration of expression of the GFP transgene in BALB/c mouse liver. These improvements result from testing
the hypothesis that induction of strong innate responses is primarily a result of the powerful enhancer
contained within the strong CMV promoter activating expression of Ad genes retained within the vector. A
DNA fragment containing four CTCF-binding sites, which was expected to act as a chromatin insulator, was
introduced 5′, 3′, or both 5′ and 3′ of a CMV-GFP cassette in an attempt to reduce activation of Ad gene
expression by the enhancer. The presence of this sequence in any of the conﬁgurations led to reduction of the
innate immune response, as assayed by mouse ear swelling, to the low level induced by a virus deleted for the
E1 region and carrying no introduced sequence. In addition, the duration of GFP expression in the liver more
than doubled. The prolonged GFP expression indicates that GFP does not play the limiting role in shutting
down vector expression. The CTCF-binding sequence introduced appears to act as a chromatin insulator in Ad
DNA, but position-independence of the elements in reducing the innate immune response indicate
unanticipated complexities in the mechanism by which Ad vectors induce innate immune responses.ol of Medicine, Department of
80045, USA. Fax: +1 303 724
ack).
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First-generation adenovirus (FG Ad) vectors, deleted for the E1A,
E1B, and E3 genes, have been widely used for transduction of humans
and non-human animals. From some of the earliest studies in vivo,
primarily in mice, it was clear that these simple vectors containing
very strong foreign viral promoters/enhancers induce strong immune
responses that limit the duration of transgene expression (Smith et al.,
1993; Choi et al., 1993). In spite of the problems associatedwith FG Ad
vectors, they remain the vector of choice for short-term in vivo studies
in certain tissues, including liver and mammary gland, in mice.
Improvements in FG Ad vectors would offer increased utility in such
studies, with fewer complicating off-target effects.There has been relatively modest study of the roles of vector
components in induction of the innate immune responses. In contrast,
the host innate response to Ad vectors has been studied in some
detail, including the roles of toll-like receptors (Appledorn et al.,
2009) and the complement pathway (Kiang et al., 2006). These
studies directed modiﬁcation of a FG Ad vector with improved
function (Seregin et al., 2010).
Studies employing FG (Stilwell and Samulski, 2004) or both FG and
helper-dependent (hd) Ad vectors (Muruve et al., 2004) have
elucidated the pattern of expression of certain cytochemokines
induced in mice. Early after transduction, expression of the cyto-
chemokines examined is similar for hd and FG vectors. At longer times
after transduction, cytochemokine expression induced by FG vectors
remains at a high level while it falls in animals transduced with hd
vectors (Muruve et al., 2004). The cytochemokines induced immedi-
ately after transduction include proteins of which synthesis and
activities are inhibited by E1A proteins during infections with the
wild-type virus: IL-6 (Janaswami et al., 1992; Takeda et al., 1994),
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(Reich et al., 1988), and likely other innate inﬂammatory mediators.
In addition to playing an important role in the inﬂammatory response
to FG Ad vectors, IFN-γ and TNF-α down-regulate the activity of the
CMV promoter (Sung et al., 2001).
In immune-suppressed patients infected with wild-type Ads, there
was a modest cytochemokine response with local infection but
dramatically increased response in both level and scope when the
infection was systemic (Haveman et al., 2010). This suggests that
wild-type Ad is less efﬁcient at countering cytochemokine expression
in cells that are not normally targeted by the virus compared to cells
that are normally infected. This is important in considering Ad vector
function, as Ad vectors have been, in the great majority of tests,
targeted to tissues that are not normally infected by the wild-type
virus in immune competent individuals.
Transient, intensive immune suppression prior to and during
transduction permits long-term transgene expression of FG Ad
vectors (Yang et al., 1996a,1996b; Kay et al., 1997; Jooss et al., 1996;
Smith et al., 1996; Stein et al., 1998; Fontanellas et al., 2010). While
immune suppression has potential for treatment of patients with FG
Ad vectors, understanding of the processes by which FG Ad vectors
induce innate and adaptive immune responses has the potential for
improvement that may lead to prolonged transgene expression
without the disadvantages associated with immune suppression or
the difﬁculties in the preparation and puriﬁcation of hd Ad vectors.
Because the host innate and adaptive immune responses are
considerably more complex than the viral counter responses,
examination of the roles of vector components that function to
induce or inhibit immune responses offers promise for improvement
of simple Ad vectors. The fact that Ad has developed mechanisms to
counter the effects of both adaptive and innate immune responses
(Reich et al., 1988; Janaswami et al., 1992; Takeda et al., 1994;
Windheim et al., 2004; Lichtenstein et al., 2004; Horwitz, 2004)
makes understanding the roles of vector components a potentially
powerful tool for functional improvement of FG Ad vectors and a
means to understand which factors act at rate-limiting steps in the
immune responses to Ad vectors.
In this study, we hypothesized that the very strong enhancer
contained within the CMV promoter plays the major role in the
induction of innate immune responses to FG vectors through itsFig. 1. Schematic structures of the left ends of the viruses encoding GFP. A: schematic struc
above the chromosome; early region transcripts are indicated below, and late region transcri
IVa2 gene of the vectors encoding GFP under the control of the CMV promoter (Table 1) used
viruses F and J. pr: promoter; pA: polyadenylation site.effects on expression of Ad genes retained within the vector. We
introduced four CTCF-binding sites in an attempt to provide
chromatin insulator function to inhibit CMV enhancer-dependent
activation of Ad genes and the presumed resultant innate immune
responses. CTCF-binding of its DNA sites leads to a number of effects.
The most widely studied of these is the insulation of gene expression
from neighboring elements, particularly enhancers (Chung et al.,
1993). CTCF also plays a number of other roles, including inhibition
and activation of transcription and X chromosome inactivation. In its
functions, CTCF interacts with a number of proteins, including
cohesin, PARP1, YY1, and RNA polymerase II (reviewed in Gaszner
and Felsenfeld, 2006; Wallace and Felsenfeld, 2007; Filippova, 2008;
Zlatanova and Caiafa, 2009; Phillips and Corces 2009; Gause et al.,
2008).
The introduction of CTCF binding sites at either or both sides of the
transgene cassette led to signiﬁcant reduction in the innate inﬂamma-
tory response to the vector and improvements in the duration of
transgene expression. Surprisingly, in contrast to the classical deﬁnition
of an insulator, CTCF-binding sites acted in a position-independent
manner to inhibit innate immune responses suggesting unexpected
mechanisms in play in the context of Ad vectors.
Results
Construction of Ad vectors containing CTCF-binding sites
E1-deleted FG Ad vectors containing a CMV promoter (CMV)-GFP
cassette in the leftward (anti-E1A) orientation (Fig. 1) were
constructed in a series of viral backbones containing no deletions
other than E1 or additionally deleted for the E3 or preterminal protein
(pTP) genes (Table 1). The leftward orientation was chosen because
results from the accompanying manuscript (Schaack et al.) indicate
that this orientation leads to a greater innate immune response, as
measured by ear swelling, than does the rightward orientation. The
leftward orientation thus should provide a more stringent test of our
primary hypothesis that the powerful foreign enhancers used in FG Ad
vectors are the major contributor to induction of innate immune
processes via activation of viral genes.
A DNA fragment containing four CTCF-binding sites (Fig. 2) was
inserted 5′ of the CMV promoter/enhancer, 3′ of the GFP codingture of the full-length viral chromosome with primary transcripts indicated by arrows
pts above, the viral chromosome. B–E: schematic structures of the left ends through the
in this study. B: the left end viruses A, C, and G. C: viruses D and I. D: viruses B, E, and I. E:
Table 1
Genotypes of the viruses used in this study. “Promoter” indicates the promoter used to
drive GFP expression.
Virus Genotype Promoter CTCF-binding site
A E1A− E1B− pTP− GFP+ CMV none
B E1A− E1B− pTP− GFP+ 3′ ins CMV 3′ of GFP coding sequence
C E1A− E1B− GFP+ CMV none
D E1A− E1B− GFP+ 5′ ins CMV 5′ of CMV promoter
E E1A− E1B− GFP+ 3′ ins CMV 3′ of GFP coding sequence
F E1A− E1B− GFP+ 5′ 3′ ins CMV 5′ and 3′ of CMV-GFP
G E1A− E1B− E3− GFP+ CMV none
H E1A− E1B− E3− GFP+ 5′ ins CMV 5′ of CMV promoter
I E1A− E1B− E3− GFP+ 3′ ins CMV 3′ of GFP coding sequence
J E1A− E1B− E3− GFP+ 5′ 3′ ins CMV 5′ and 3′ of CMV-GFP
K E1A− E1B− none none
L E1A 289R− pTP− none none
M E1A− E1B− LacZ+ CMV none
N E3− (Ad5dl309) none none
O E1A− E1B− E3− GFP+ E1A none
P E1A− E1B− E3− LacZ+ CMV none
138 J. Schaack et al. / Virology 412 (2011) 136–145sequence, or in both the 5′ and 3′ positions in a variety of viral
backbones (Table 1). As controls, vectors identical except that they did
not contain introduced CTCF-binding sites were constructed. The
vectors were used to test our hypothesis that the major contributor to
the induction of the innate inﬂammatory response by FG Ad vectors
containing very strong foreign enhancers is activation of expression of
Ad genes retained in the vector by the enhancers. In particular, we
hypothesized that activation of pIX expression, which does not occur
in cells infected by wild-type Ad5 until after the onset of viral DNA
synthesis (Wilson et al., 1979; Crossland and Raskas, 1983), was likely
to play an important role (Nakai et al., 2007).CTCF-binding sites reduce ear swelling induced by Ad vectors
Swelling assays after subdermal injection of the viruses into mouse
ears were used as a sensitive, indirect test of induction of total innate
immune responses (Moorhead et al., 1999; Schaack et al., 2004;
Schaack, 2005). Vectors lacking the CTCF-binding sites induced
statistically identical high levels of swelling independent of the E3 and
pTP genes (Fig. 3). In contrast, all of the vectors containing one or two
sets of 4 CTCF-binding sites, regardless of their positions, induced
statistically identical levels of swelling thatwere equal to the low level of
swelling induced by a control virus deleted for the E1 region but
containing no expression cassette. Surprisingly, the suppression of ear
swelling by the CTCF-binding sites occurred even when the sites were
downstream of the GFP coding sequence. Thus, the effect of the CTCF-
binding sites on the overall innate immune response is position-
independent.Fig. 2. Sequence of the CTCF-binding site-containing DNA fragment introduced into
adenovirus vectors. The minimal chromatin insulator element (a generous gift of G.
Felsenfeld), underlined with the CTCF-binding sequences italicized and bold faced, was
dimerized and inserted into the Ad chromosome on either or both sides of a CMV
promoter-GFP cassette. The consensus CTCF-binding sequence (Kim et al., 2007) is
presented below with the most highly conserved bases bold faced.CTCF-binding sites increase the duration of transgene expression
GFP-encoding vectors were injected into mice via the tail vein to
target the liver. GFP expression was determined by ﬂuorescence
microscopy of liver sections. Vectors lacking CTCF-binding sites directed
strong levels of GFP expression that were independent of the presence
or absence of the E3 or preterminal protein genes on day 3 after
injection, with little expression by day 7 (Fig. 4A and data not shown).
All vectors containing CTCF-binding sites 5′, 3′, or 5′ and 3′ of the CMV-
GFP cassette directed levels of GFP expression that were similar to
expression directed by vectors lacking the CTCF-binding sites on day 3
(Fig. 4 and data not shown). However, the CTCF-binding site-containing
vectors directed signiﬁcantly greater GFP expression at days 7 and day
14 than did the vector lacking the CTCF-binding sites (Fig. 4B and data
not shown).GFPexpression at14 dayswasgreater thanatday7 in livers
transduced by vectors lacking CTCF-binding sites (Fig. 4B). Detectable
GFP ﬂuorescence was apparent 18 days after injection of CTCF-binding
site-containing vectors, but was no longer apparent by day 21 (data not
shown). Thus, the CTCF-binding sites led to increased duration of high-
level GFP expression, again in a position-independent manner.
Quantitative rtPCR analysis of Ad gene expression in mouse liver
Livers were transduced via tail vein injection with a variety of
viruses. Three days after injection, mice were killed and livers
harvested. Liver sections from mice transduced with the GFP-
encoding vectors again showed similar ﬂuorescence between mice
injected with vectors containing or not containing CTCF-binding sites
(data not shown). Total RNA was tested in duplicate for vector-
encoded RNA expression by quantitative rtPCR for a variety of Ad
genes as well as the GFP gene (Fig. 5) using primers listed in Materials
and methods. Data were normalized to 18S rRNA. For the viruses
encoding GFP, data were further normalized to GFP expression.
pIX RNA expression varied in surprising fashion (Fig. 5). pIX RNAwas
relatively highly expressed in livers transduced by each of the CMV-GFP
vectors andwasonlymodestly lower in thepresenceof theCTCF-binding
sites between the CMV and pIX promoters (virus D, Table 1). pIX RNA
expression was signiﬁcantly higher in cells transduced with the vector
containing CTCF-binding sites placed 3′ of the GFP coding sequence
(virus E, Table 1). Given that ear swellingwas at the same low level in the
two vectors containing the introduced CTCF-binding sites andwasmuch
higher in the absence of CTCF-binding sites, pIX RNA expression levels
correlate poorly with the level of the innate inﬂammatory response.
Further, because of the similarity in GFP RNA levels between livers
transduced with virus C lacking CTCF-binding sites and virus D with
CTCF-binding sites between the CMV and pIX promoters, this evidence
raises the question of whether the CTCF-binding sites act as classically-
deﬁned chromatin insulators in Ad5 chromatin.
Expression of pIX RNA was apparent at a very low level in cells
transduced with the empty vector (virus K, Table 1) and at a relatively
low level in cells transduced by the non-inﬂammatory virus L (Table 1)
deleted for the E1A 289R-coding sequence and the pTP gene. The signal
in cells transduced by virus L likely represents E1B RNA, as the pIX gene
is nestedwithin the 3′ end of the E1B transcription unit. The low level of
pIX expression in cells transduced with virus Kmay result from the loss
of inhibition of the pIX promoter that occurs by transcription read-
through from the E1B promoter (Vales and Darnell, 1989).
Expression of L1 RNA, which normally occurs at a low level prior to
Ad DNA replication in cells infected with wild-type Ad5 (Shaw and Ziff,
1980) and of which promoter (the major late promoter) lies between
the3′ endsof the pIX andE2B coding sequences (Fig. 5),was apparent in
cells transduced with each of the 3 GFP vectors. Surprisingly, L1
expressionwas 60-fold higher in the vector with the CTCF-binding sites
5′ of the GFP gene (virus D) and 30-fold higher in the vector with no
introduced CTCF-binding sites (virus C) than in livers transduced by
vector E with the CTCF-binding sites inserted 3′ of the GFP coding
Fig. 3. Ear swelling induced by the viruses. 2×1011 particles of each puriﬁed virus were injected subdermally into BALB/c mouse ears. Ear thickness measurements were taken
immediately prior to and 24, 48, and 72 h after injection. All ears showed very similar rates of decay of ear swelling (data not shown). Data, with swelling induced by injection of
buffer alone subtracted, are presented for the 24 hr measurements. All vectors (viruses A–K, Table 1) are deleted for the E1A and E1B genes with other genes wild type except as
noted.
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correlates poorly with the intensity of the innate immune response.
E2A RNA was expressed at moderate to low levels in cells
transduced with each of the viruses except for the empty vector
(virus K), where no expression was apparent, and the virus encoding
the E1A 12S mRNA (virus L), where a somewhat higher level was
apparent. The E1A 243R protein likely activates the E2A promoter
through its effects on the transcription factor E2F, which plays an
important role in E2 transcription (Bagchi et al., 1990). There was no
apparent expression of either E2B, encoding the essential replication
proteins DNA pol and pTP, or IVa2, which lies within the 3′ end of the
E2B transcription unit. However, the pTP gene, which lies in the E2B
transcription region, has an effect on ear swelling (Schaack et al.,
2004), suggesting that pTP is expressed, at least at a low level, in
mouse ears. E3 expression was similar after transduction by the
vectors with no CTCF-binding sites (virus C) or containing CTCF-
binding sites 5′ of the CMV promoter/enhancer (virus D) but was
signiﬁcantly lower when the CTCF-binding sites were 3′ of the GFP
coding sequence (virus E). Finally, E4 expression was very low in cellsFig. 4. GFP expression as a function of time after transduction with CTCF-binding site-contain
encoding GFP. The presence of CTCF-binding sites (ins) is indicated. A) GFP ﬂuorescence 3 an
conditions. B) GFP ﬂuorescence was tested 3, 7, and 14 days after transduction with vectors d
B) or virus C (Table 1). All images were collected using the same exposure conditions.transduced by the empty vector (virus K) and was expressed at
higher, similar, but still modest levels in livers transduced by the other
viruses tested. Thus, E4 expression appears to be relatively indepen-
dent of the introduced CTCF-binding sites.
Placement of CTCF-binding sites between the CMV enhancer and
the pIX promoter was expected to signiﬁcantly reduce the innate
response and increase duration of transgene expression. In contrast,
placement of the CTCF-binding sites downstream of the GFP coding
sequence was expected to have little or no effect. The ﬁnding that the
chromatin insulator had position-independent effects on the innate
inﬂammatory response and the duration of transgene expression
therefore further questions whether the CTCF-binding sites are acting
as chromatin insulators.
CTCF binds to the CTCF-binding sites in the adenovirus vectors
The factor CTCF binds to chromatin insulators and plays an
important role in chromatin insulator function (Chung et al., 1993).
Because CTCF-binding sequences do not appear to be acting asing viruses. Mice were injected via the tail vein to target liver with the different vectors
d 7 days after transduction of liver. All images were collected using the same exposure
eleted for the pTP gene carrying CTCF-binding sites 3′ of the GFP coding sequence (virus
Fig. 5. Expression of adenovirus RNAs in mouse liver as a function of the presence of four CTCF-binding sites. Mice were injected via the tail vein to transduce livers. Mice were killed
and livers harvested after 3 days. RNA prepared from livers was tested for expression of various genes by qRTPCR in duplicate. RNA levels normalized to 18S rRNA and, for viruses
encoding GFP, secondarily to GFP expression, are presented schematically, with genes arranged from the left end to the right end of the Ad chromosome and the direction of
transcription indicated by the arrows. The E2 promoter, which drives expression of both E2A and E2BmRNAs, lies immediately upstream of the E2A coding region. The IVa2 gene lies
within the 3′ end of the E2B transcription unit. The positions of the introduced CTCF-binding sites and the major late promoter (MLP) are indicated by dashed vertical lines. Virus
identities are from Table 1. *E3 is partially deleted in this virus.
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binds the CTCF-binding sites introduced into the vectors. ChIP assays
were performed from transduced livers using polyclonal antiserum
recognizing human CTCF expected to cross react with murine CTCF.
CTCF-binding sites on both sides of the GFP cassette were immuno-
precipitated (Fig. 6), indicating that CTCF binds to the CTCF-binding
sequences in the context of Ad vector chromatin.
Ad vector containing CTCF-binding sites induces a neutralizing immune
response
To test for the dependence of induction of a neutralizing response
on the CTCF-binding sites, a super-transduction protocol was used. An
unmodiﬁed FG vector encoding LacZ (virus M, Table 1) was injected
via the tail vein 28 days after injection of buffer, the virus encoding
GFP with CTCF-binding sites 3′ of the gene (virus E), or the virus
encoding GFP with no CTCF-binding sites (virus C). Staining of liver
sections with X-gal was negative after supertransduction, suggesting
that the presence of the CTCF-binding sites did not affect the
neutralizing response induced by the vector (Fig. 7).Fig. 6. Chromosomal immunoprecipitation of CTCF bound to adenovirus DNA.
CTCF-bound DNA was immunoprecipitated from liver cells transduced with Ad-GFP
(GFP), Ad-GFP with a CTCF-binding site inserted 5′ of the GFP gene (5′ ins), and Ad-GFP
with a CTCF-binding site inserted 3′ of the GFP gene (3′ ins). PCR was performed for 40
cycles. DNA markers are indicated in bp.Hematoxylin and eosin staining of liver sections did not demon-
strate a cell inﬁltrate regardless of whether transduction of the liver
was primary (injection of the LacZ-encoding vector after mock
injection) or secondary when no transduction by the LacZ-encoding
virus was evident (Fig. 7). The absence of an apparent cell inﬁltrate in
response to liver transduction in BALB/c mice has been observed
previously (Schaack et al., 2004).Fig. 7. Supertransduction of livers with Ad-LacZ. Livers were mock-transduced (top
panel) or transduced with vectors encoding GFP without CTCF binding sites (virus C,
middle panel) or with CTCF binding sites (virus D, bottom panel) via tail vein injections.
28 days later, the livers were transduced with Ad-LacZ (virus O, Table 1) via tail vein
injection. 3 days later, livers were collected, sectioned, and sections stained with X-gal
to visualize LacZ activity and then with hematoxylin and eosin.
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The CMV promoter causes absence of local chromatin structure in
CMV DNA (Nitzsche et al., 2008). To test whether the presence of the
CMV promoter causes global changes in Ad vector chromatin
structure, we used a “dot” formation assay after transduction of
MEFs (Chen et al., 2007; Walkiewicz et al., 2009). In this assay,
antibodies against Ad protein VII, which is the major Ad chromatin
protein, are used to determine whether protein VII is highly localized
through binding to Ad DNA to yield foci or dots of protein VII signal, or
not bound to Ad DNA, in which case diffuse nuclear staining is
apparent (Chen et al., 2007; Walkiewicz et al., 2009). In the presence
of E1A protein, which activates expression of all of the Ad early region
genes, dots are lost as a function of time between 4 and 16 hr after
infection, even when Ad DNA cannot be replicated (Chen et al., 2007).
As expected (Chen et al., 2007; Walkiewicz et al., 2009), the
control, phenotypically wild-type dl309 (virus N), exhibited signiﬁ-
cant loss of localized protein VII at 16 hr (Fig. 8). In contrast, for virus
O, in which the E1A promoter directs GFP expression, the localization
of protein VII at 4 and 16 hr is indistinguishable, suggesting that the
presence of the relatively weak E1A promoter driving transgene
expression does not lead to signiﬁcant chromatin rearrangement. The
pTP deletion mutant virus encoding GFP (virus A), which does not
have introduced CTCF-binding sites, exhibited signiﬁcant loss of dots,
suggesting that the presence of the CMV promoter leads to global
rearrangement of Ad chromatin and that protein VII relocalization is
not dependent on vector DNA replication because deletion of the pTP
gene results in replication incompetence (Schaack et al., 1996).
Chromatin rearrangement in cells transduced by viruses C (no CTCF-
binding sites inserted), D (CTCF-binding sites 5′ of the CMV enhancer)
and E (CTCF-binding sites 3′ of the CMV enhancer) correlate well with
the quantitative rtPCR results. There is little loss of protein VII dots in
cells transduced by virus E (Fig. 8), which exhibited very little
expression of L1 and early region genes in mouse liver (Fig. 5). In
contrast, there is signiﬁcant loss of localized protein VII signal in cells
transduced by virus C and cells transduced by virus D (Fig. 8). Both of
these vectors exhibited relatively high-level expression of L1 and early
region gene RNA expression in mouse liver (Fig. 5).Fig. 8. Loss of protein VII from Ad chromosomes in vitro. Ad5dl309, a control virus phenotyp
MEFs. Four and 16 hr after transduction, cells were ﬁxed and stained with antibody against p
protein VII staining due to binding to the Ad chromosome.Discussion
In this study, we have demonstrated that introduction of a DNA
fragment containing 4 CTCF-binding sites into the Ad vector
chromosome signiﬁcantly reduces the innate inﬂammatory response
induced by the vector and prolongs transgene expression in mouse
liver. The CTCF-binding sites were introduced to test our hypothesis
that Ad genes retained in the vector are transcriptionally activated by
the powerful enhancer contained within the CMV promoter and that
the enhancer is indirectly responsible for induction of the majority of
the innate immune response induced by the vector through increased
expression of Ad genes. In particular, we expected that pIX expression,
which normally occurs only after the onset of viral DNA replication
(Crossland and Raskas, 1983), would have a signiﬁcant effect on
induction of the innate inﬂammatory response. We hypothesized that
pIX induces inﬂammatory effects that normally are blocked by early
region proteins, including E1A and E1B (Schaack et al., 2004), of which
expression precedes pIX in infections by the wild-type virus.
However, our results demonstrate that the mechanism by which the
innate inﬂammatory response is mediated correlates poorly with the
level of pIX RNA as well as with RNA levels from any of the individual
Ad genes tested at 72 hr after transduction.
Chromatin insulators have been used in FG Ad vectors previously,
in particular in attempts to block the effects on tissue-speciﬁc
promoters of transcription from the inverted terminal repeat
(Steinwaerder and Lieber, 2000; Cheng et al., 2004; Ren et al., 2006;
Rohmer et al., 2008; Danielsson et al., 2008). The introduction of poly
A sites rather than chromatin insulators had similar effects, raising the
possibility that themechanism involved differs from simple insulation
of the promoters. In addition, chromatin insulators have been used to
block enhancer effects in a two-gene conditionally replicating anti-
tumor vector (Martin-Duque et al., 2004) and to block epigenetic
effects from prokaryotic stuffer DNA (Ross et al., 2009).
A search of the Ad5 genome demonstrated neither any strong
matches for the consensus CTCF-binding site (Essien et al., 2009; Kim
et al., 2007) nor clustering of potentially weaker binding sites (data
not shown). Thus, it appears unlikely that our results are affected by
naturally occurring CTCF-binding sequences.ically wild-type in tissue culture, and other viruses as indicated were used to transduce
rotein VII and counterstained with DAPI to identify nuclei. Dots are positive for localized
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Our results raise the possibility that the CTCF-binding sites do not
act as chromatin insulators in Ad5 chromatin because pIX RNA is
expressed at similar levels in livers transduced by virus C (Table 1)
lacking introduced CTCF-binding sites and virus D with CTCF-binding
sites introduced between the CMV enhancer and the pIX promoter
(Fig. 5). However, there are complicating factors that result from the
strong inﬂammatory response provoked by the vector lacking
introduced CTCF-binding sites. It is likely that many, if not all, of the
Ad promoters are responsive, either negatively or positively, to
inﬂammatory stimuli. For example, TNF-α upregulates the E3
promoter (Deryckere et al., 1995). The CMV promoter is inhibited
by IFN-γ and TNF-α (Qin et al., 1997), and the pIX promoter may be
inhibited by inﬂammatory mediators.
The pIX promoter is simple, with binding sites for Sp1 and RBP as
well as a TATA box (Babiss and Vales, 1991). RBP, when bound ﬁrst to
the promoter in vitro, represses transcription, although it does not
repress transcription when SPI, TFIIA, and TFIID are allowed to bind
ﬁrst (Olave et al., 1998). It is possible that RBP acts to inhibit
transcription of the pIX gene while or after the strong innate immune
response develops, leading to reduced pIX RNA synthesis in the
absence of CTCF-binding sites in the Ad chromosome.
This argument suggests that the proper comparison for determi-
nation of chromatin insulator effects of the CTCF-binding site
fragment is virus E, with CTCF-binding sites 3′ of the GFP coding
sequence, and virus D, with CTCF-binding sites 5′ of the CMV
enhancer. These viruses induce statistically identical levels of ear
swelling, so it is reasonable to assume that inﬂammation-dependent
effects on transcription from the pIX promoter are similar between
livers transduced by the two vectors. The chromatin insulator effect of
the four CTCF-binding sites would thus be the ratio of pIX expression
directed by the virus with CTCF sites 3′ of the GFP coding sequence:
pIX expression directed by the virus with CTCF binding sites between
the CMV enhancer and the pIX promoter, or approximately 4-fold. The
relatively modest effect of the chromatin insulator may result from
the fact that Ad DNA is bound by protein VII (Chatterjee et al., 1986)
rather than histones prior to transcriptional activation of a major part
of the viral chromosome.The role of pIX in induction of the innate immune response
pIX is normally expressed only after the onset of viral DNA
replication (Crossland and Raskas, 1983). However, as demonstrated
by Nelson and Kay (1997) using vectors of which DNA was modiﬁed
by methylation at XhoI sites, FG Ad vector DNA is not replicated or is,
at most, replicated to a very low level after transduction of mouse
liver. Thus, it appears that pIX expression in livers transduced by FG
Ad vectors bypasses the normal transcriptional control.
pIX expression is normally inhibited by transcription readthrough
from the E1B promoter (Vales and Darnell, 1989) in a complex
manner. E1B transcription is activated by transcription read through
from the E1A promoter (Falck-Pedersen et al., 1985; Maxﬁeld and
Spector, 1997; Shen and Spector, 2003) as well as by E1A protein
(Jones and Shenk, 1979). Deletion of the E1A and E1B promoters and
coding sequences thus likely leads to slightly more readily activated
pIX expression in the absence of DNA replication as seen in liver
transduced by the control virus K. The higher levels of pIX expression
apparent in liver transduced with viruses containing the CMV
promoter therefore likely result from effects of the CMV enhancer.
In infections by wild-type Ad5, pIX is expressed only after early
region genes, including E1A and E1B, which act to block host innate
immune responses, have been expressed for several hours. This raises
the possibility that pIX is inﬂammatory and that early region proteins
act to block inﬂammatory responses induced by pIX.Nakai et al. (2007) demonstrated that an Ad vector containing the
CMV promoter driving transgene expression in the rightward
orientation led to splicing of the transgene RNA in-frame into the
pIX coding sequence. When the weaker but still very strong EFIα
promoter was used in place of the CMV promoter, expression of the
pIX fusion protein occurred at a signiﬁcantly lower level and
transgene expression was prolonged. In the rightward orientation,
transcription from the CMV or EF1α promoter may inhibit expression
from the pIX promoter by transcription read through, as the E1B
promoter does. The conclusion from this study was that pIX
expression might play an important role in the induction of immune
responses that limit Ad vector function.
In contrast to the conclusions of Nakai et al. (2007) and our
expectations, our results suggest that pIX does not play the limiting
role in the innate immune response to Ad vectors. Neither the similar,
high levels of pIX RNA expression induced by the unmodiﬁed vector
and the vector with CTCF-binding sites between the CMV enhancer
and the pIX promoter nor the signiﬁcantly higher level of pIX RNA
expression induced when the CTCF-binding sites were placed 3′ of the
GFP gene correlates with the innate inﬂammatory response induced
or the duration of GFP expression.
Evidence that the CMV enhancer affects the limiting role in transgene
expression
Our results demonstrate that the duration of GFP expression
differs dependent on the presence or absence of the CTCF-binding
sites when the CMV promoter is used. The mechanism by which the
effects of the CTCF-binding sites, particularly CTCF-binding sites 3′ of
the GFP coding sequence, occur is not clear. However, the reduction in
the innate inﬂammatory response and the prolonged transgene
expression in livers transduced by vectors that have CTCF-binding
sites inserted offers support for our hypothesis that the very strong
enhancers in the foreign promoters typically used in FG Ad vectors are
primarily responsible for limiting the duration of transgene
expression.
The deﬁned activities of CTCF bound to its sites in chromatin
include transcriptional activation, transcriptional repression, tran-
scriptional silencing, and chromatin insulation (Nikolaev et al., 2009;
Phillips and Corces, 2009). CTCF-DNA complexes include a variety of
additional proteins (Zlatanova and Caiafa, 2009) that contribute to the
effects induced. While the nature of the CTCF complex bound to Ad
DNA is not clear, the demonstration that CTCF binds the Ad DNA
fragments that contain the introduced CTCF-binding sequences
suggests that it plays a key role in the effects that we observed,
including reduction of the innate immune response and prolonged
transgene expression. The position independence of the effects of the
CTCF-binding sites suggests that they affect the innate immune
response to the vector through a novel mechanism.
Shut off of GFP expression
Examination of GFP expression (Fig. 4) permits a rough analysis of
the kinetics of shut off of GFP expression. The half-life of GFP is
approximately 26 hr in mouse LA-9 cells (Corish and Tyler-Smith,
1999) and the half-life of GFP mRNA in HEK293T cells is approxi-
mately 7 hr (Sacchettia et al., 2001). GFP expression at 7 days after
transduction appears to be less than 10% of that at 3 days after
transduction with virus G (Fig. 4), which lacks introduced CTCF-
binding sites. Assuming that the half-lives of GFP and GFP mRNA are
similar in liver and in the tissue culture cells in which they were
tested, GFP synthesis would have ceased on or about day 4 to permit
decay of ﬂuorescence to the level apparent on day 7 (Fig. 4). Further,
assuming that the shut off of GFP expression occurs at the level of
transcription and not translation, GFP mRNA synthesis would have to
be shut off on days 3–4. In contrast, GFP synthesis would have to have
143J. Schaack et al. / Virology 412 (2011) 136–145shut down on or about day 11 and GFP mRNA synthesis shut off on
days 10–11 to yield the ﬂuorescence signal apparent on day 14 in liver
transduced by the vectors containing CTCF-binding sequences (Fig. 4
and data not shown). Therefore, we estimate the effect of the inserted
CTCF-binding sites appears to be approximately 3-fold in terms of
duration of transgene expression.
Validation of use of the mouse ear-swelling model for vector design
The correlation between ear swelling and effectiveness of the
vectors in liver offers validation for the use of the mouse ear-swelling
model as a sensitive and relatively rapid indicator of the total innate
immune response induced by the vector. The ear-swelling model is
dependent on the overall innate response and independent of the
identiﬁcation of speciﬁc cytochemokines induced. It has allowed us to
identify virus mutants and vectors that span a wide range of abilities
to induce the overall innate response as well as some of the Ad genes
that affect the innate response (Moorhead et al., 1999; Schaack et al.
2004; Schaack et al., accompanying manuscript; this study). Deter-
mination of the cytochemokines induced by these viruses will provide
baselines for modestly inﬂammatory and highly inﬂammatory viruses
that will aid in determination of which cytochemokines play limiting
roles in the immune responses to Ad vectors.
Conclusion
This analysis leaves questions regarding the activity of the CTCF-
binding sites: 1) Why is L1 expression 60-fold lower in liver
transduced by virus E, with CTCF-binding sites 3′ of the GFP coding
sequence, than in liver transduced by virus D, with CTCF binding sites
between the CMV enhancer and the pIX gene? 2) Why is early region
gene expression, in particular E3 expression, so different in livers
transduced by virus E, with CTCF-binding sites 3′ of the GFP coding
and virus D, with CTCF binding sites 5′ of the CMV enhancer? 3) Why
is early region gene expression so similar in livers transduced by the
highly inﬂammatory virus C, lacking introduced CTCF-binding sites,
and themodestly inﬂammatory virus D, containing CTCF-binding sites
5′ of the CMV enhancer? 4) Most importantly, what is the mechanism
(s) by which CTCF-binding sites reduce the innate inﬂammatory
response induced by the Ad vectors and prolong transgene
expression?
FG Ad vectors remain the gene-delivery vectors of choice for
studies of metabolic processes in mouse liver and mammary gland,
among other tissues. The results that we have presented here provide
improvement of these vectors for transduction in vivo with prolonged
timewindows in which analyses can be done. In addition, the reduced
inﬂammatory response should lead to fewer off-target effects. Finally,
addressing questions that have been raised by this study offers
promise for further improvements to Ad vectors.
Materials and methods
Cell lines
HEK293 cells (Graham et al., 1977) and HEK293-pTP cells (Schaack
et al, 1995; Schaack et al., unpublished), which constitutively express
Ad preterminal protein, were grown in DMEM containing high
glucose supplemented with 10% bovine calf serum.
Construction and growth of viruses
Viruses (Table 1 and Fig. 1) were constructed using the method of
He et al. (1998) as previously modiﬁed (Orlicky and Schaack, 2001).
Viruses were grown in either HEK 293 cells or HEK 293-pTP cells. At
full CPE, infected cells were collected, frozen and thawed 3× to release
the virus, cellular debris was pelleted, and the virus-containingsupernatant was puriﬁed and concentrated by step- and isopycnic-
gradient centrifugation. Viral particle titers were determined by
OD260, with one OD260=1012 particles/ml.
The plasmid with the CMV major immediate early (CMV)
promoter-GFP gene introduced in the more inﬂammatory anti-E1A
orientation (see accompanying paper Fig. 1) with the SV40 poly A site
introduced downstream of the promoter was used for all new
constructs. A DNA fragment containing 4 CTCF-binding sites (Fig. 2)
was introduced downstream of the poly A site and/or upstream of the
CMV promoter.
Vectors containing a single set of CTCF-binding sites stably
maintained the GFP cassette as demonstrated by plaque assays after
repeated rounds of growth. In contrast, the GFP cassette was unstable
in vectors containing chromatin insulators ﬂanking the gene. Deletion
of the GFP cassette appears to occur through recombination between
the chromatin insulators, with retention of a single chromatin
insulator element, as demonstrated by PCR and restriction digestion
analyses of plaque-puriﬁed, GFP-negative vectors (data not shown),
raising the possibility that a small chromosomal loop forms between
the 2 sets of 4 CTCF-binding sites after binding of CTCF. After four
rounds of growth of the vectors containing the pTP gene and
chromatin insulators ﬂanking the CMV-GFP cassette (viruses D and
E, Table 1) to produce high titer stocks, examination of approximately
50 plaques showed no apparent loss of GFP expression in HEK 293
cells infected with viruses F and J (Table 1). However, after a second
set of rounds of growth, approximately 20% of the plaques from
viruses containing CTCF sites 5′ of the CMVpromoter and 3′ of the GFP
coding sequence showed loss of GFP expression. Data from vectors
containing two chromatin insulators are presented from ﬁrst rounds
of growth only.
A vector deleted for the pTP gene and containing the GFP cassette
ﬂanked by 2 sets of CTCF-binding sites showed signiﬁcant loss of GFP
expression as determined by plaque assays after the ﬁrst set of rounds
of growth and was not used in these studies.
Injections of mice and analysis of swelling
All procedures involving animals followed the guidelines of, and
were approved by, the University of Colorado Institutional Animal
Care and Use Committee. Female, 6-week-old BALB/c mice were
anesthetized by intraperitoneal injection of avertin prior to the
measurement of ears and virus injection.
Virus stocks were diluted in PBS. 2×1010 particles in 10 μl were
injected subdermally into both ears of each mouse tested. Ear
thickness was measured immediately prior to and every 24 hr
through 72 hr after injection using a Mitutoyo model 7326 engineer's
micrometer. Ear measurements are reported in units of 10−4 in. Ears
that developed a hematoma were excluded from analysis. Data
represent the average values from 6 or more ears after subtraction of
swelling induced by injection of buffer alone, ± the standard error of
the mean. Swelling induced by injection of ears with buffer alone
averaged 4.80±0.24 units for all mice analyzed. Statistical signiﬁ-
cance was determined using the 2-tailed t test.
For liver transduction, 1011 puriﬁed particles diluted to 200 μl in
PBS were injected into the tail vein. Mice were killed at various times
as noted after transduction. For analysis of GFP expression, livers were
harvested and ﬁxed overnight in formalin (Fisher Scientiﬁc) or in 4%
paraformaldehyde (Fisher Scientiﬁc) for 3 hr (no differences in GFP
ﬂuorescence were apparent between the ﬁxation processes; data not
shown), then cryoprotected by overnight incubation at 4 °C in PBS
containing 30% w/v sucrose. Liver blocks were then frozen and
sectioned using a Leica CM 1850 cryotome. Sections afﬁxed to slides
were examined for GFP ﬂuorescence and images collected using a
Nikon TE2000-E UV microscope. For analysis of supertransduction,
adjacent sections were stained with X-gal followed by hematoxylin
and eosin and examined microscopically.
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Three days after transduction ofmouse livers, total RNAwas prepared
from livers using Trizol (Invitrogen) extraction. cDNA was synthesized
using oligo dT as primer. qrtPCR was performed using the following
primers: E2A, GGTAGCTGCCTTCCCAAAA and ACTACGGTGCGAGTGCAAC;
E2B GGACAGCCTTTTCGTCACC and CATGCTTTTTGATGCGTTTC; E3 GAG-
CAACAGCGCATGAATC and AGATACCCCTTTTGCACTGG; E4 CCATG-
TAGGCGTGGACTTCT and GGCTGCTGTCCAACTTGC; p IX
TTTGACCCGGGAACTTAATG and AAGCCTTCAGGGCAGAAAC; L1 AGCCTG-
GAGGCAACCCTA and AAGCCTTCAGGGCAGAAAC; IVa2 CACCGTGACCCA-
GACTACG and GCCAGGGTCATGTCTTTCC; GFP GAAGCGCGATCACATGGT
and CCATGCCGAGAGTGATCC. SYBR green was used to quantify PCR
products.
Chromosomal immunoprecipitation
Binding of CTCF to the insulator sequences introduced into the
vectors was determined 3 days after transduction of mouse liver via
tail vein injection of 1011 virus particles. DNA isolated by Trizol
(Invitrogen) extraction was sheared to an average of 1 kb and
immunoprecipitated using polyclonal antiserum against human
CTCF (Fisher Scientiﬁc) that cross reacts with murine CTCF. ChIP
analyses were done following the protocol of the Farnham lab (http://
www.genomecenter.ucdavis.edu/farnham/protocol.html; last visited
6/30/10). Oligonucleotides used are: TTCTTTCCCACCCTTAACCA and
TAATGCATGGCGGTAATACG for the virus with the CTCF-binding sites
inserted 5′ of the CMV promoter and TCGCGGGAAAACTGAATAAG and
GCTCAGATCCAAGCTTGTCG for the virus with the CTCF-binding sites
inserted 3′ of the CMV promoter.
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